A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease (Q64673178)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease |
clinical trial |
Statements
A Phase 3 Extension, Multicenter, Double-Blind, Long-Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Alzheimer's Disease Who Participated in Study ELN115727-301 or Study ELN115727-302. (English)
0 references
July 2009
0 references
September 2012
0 references
896
0 references
51 year
0 references